Hope
for Healing,
elecell.
With a foundation in biomimetic current technology, elecell is trailblazing next-generation regenerative medicine. Our mission is to conduct research that swiftly and practically enhances human lives, reshaping the healthcare landscape and offering hope and solutions where they are most needed.
Our Purpose.
We aim to heal and promote a healthier
future for those who have been wounded,
using innovative biological and medical
technology commercialization.
Core Values.
We are dedicated to researching and swiftly commercializing groundbreaking bio and medical technologies to improve human life. Our mission is to support individuals affected by injuries, illnesses, and chronic diseases, offering solutions for the best possible quality of life.
Trust.
By providing safe and effective solutions backed by scientific studies, we cultivate trust with our customers.
Impact.
Our mission is to provide cutting-edge solutions that improve health and elevate quality of life.
Sustainability.
In research, product development, and business operations, we uphold sustainable practices and environmental responsibility.
The world's first wound
treatment technology using
bio-similar current.
elecell's devices for tissue regeneration and wound healing, utilizing biomimetic currents, promise life-changing outcomes for individuals dealing with bodily damage, offering potentially life-saving solutions.
· Biomimetic current-based portable wound treatment device.
· Natural product-based recovery support.
· Electrical stimulation-based muscle cell therapy.
Core Technology.
Biomimetic current-based portable wound treatment device.
Our next-gen wound healing technology utilizes self-generated electrical stimulation. We've created a biomimetic current self-generation system that enhances cell regeneration to speed up wound healing. This innovative solution is non-invasive and portable, providing treatment for both minor and severe wounds without any side effects.
Natural product-based recovery support.
Our innovation is a natural anti-inflammatory topical treatment made from plant-derived compounds and enzymes. We found natural ingredients that effectively enhance inflammation relief during the body's healing process. Scientific research has demonstrated that these natural components are officially proven to be safer and more effective than traditional anti-inflammatory drugs.
Electrical stimulation-based muscle cell therapy.
Our biomimetic current stimulation system has led to the creation of an advanced muscle cell therapy technology. By mimicking the body's natural electrical impulses, this technology facilitates muscle regeneration and rehabilitation. It provides groundbreaking solutions for individuals recovering from injuries or aiming to enhance muscle function. We are committed to optimizing the technology's efficacy and safety through ongoing research and cooperation with medical experts.
Team.
elecell was established by Korea’s top research professionals in medical science, biomedical engineering, biotechnology, and life chemistry. We have devoted ourselves to developing revolutionary solutions for healing and health, leading to the birth of our vision to broaden the possibilities in healthcare and drive transformative changes.
News.
February 21, 2025
Successfully Holds Kick-off Meeting to Celebrate Deep Tech TIPS Fast-Track Selection
Successfully Holds Kick-off Meeting to Celebrate Deep Tech TIPS Fast-Track Selection
February 14, 2025
elecell’s Research on Reactive Oxygen Species Removal Technology for Wound Healing Published in a Leading International Biomaterials Journal (BioactiveMaterials, IF=18.0)
elecell’s Research on Reactive Oxygen Species Removal Technology for Wound Healing Published in a Leading International Biomaterials Journal (BioactiveMaterials, IF=18.0)
February 5, 2025
elecell awarded the top prize at the R&D Special Zone Deep Tech Scale-up IR Contest.
elecell awarded the top prize at the R&D Special Zone Deep Tech Scale-up IR Contest.
January 6, 2025
elecell & IMT Co., Ltd. signed a business agreement to commercialize innovative bio-medical technology
On January 25, 2025, at the headquarters of iMediTech Inc. (IMT) in Gwangju, the medical device manufacturing specialist IMT and the bio-medical technology company elecell signed a Memorandum of Understanding (MOU).
Bio and medical technology
solutions leading to a brighter and
healthier future , Please support
elecell's journey.
Backed by.
Let's talk .
Through this partnership, we can advance biomimetic current-based tissue regeneration and wound healing technologies and share groundbreaking solutions. Learn more about our partnership with Eleccell and join us as we strive to bring the world's first next-generation treatments to market.
Partnerships enable us to advance our biomimetic current-based tissue regeneration and wound healing technologies and distribute cutting-edge solutions. Discover more about partnering with elecell and join us in our mission to advance and deploy the world’s first next-generation therapies.
Let's talk.
Partnerships enable us to advance our biomimetic current-based tissue regeneration and wound healing technologies and distribute cutting-edge solutions. Discover more about partnering with elecell and join us in our mission to advance and deploy the world’s first next-generation therapies.